KBC Group NV Lowers Stake in Synopsys, Inc. $SNPS

KBC Group NV reduced its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 21.8% in the first quarter, according to its most recent filing with the SEC. The fund owned 129,445 shares of the semiconductor company’s stock after selling 36,151 shares during the period. KBC Group NV’s holdings in Synopsys were worth $51,323,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Sankala Group LLC purchased a new stake in Synopsys during the fourth quarter valued at about $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new position in shares of Synopsys in the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd purchased a new position in shares of Synopsys in the 4th quarter worth about $28,000. Atlas Capital Advisors Inc. bought a new position in shares of Synopsys during the 4th quarter valued at about $32,000. Finally, Phillip James Consulting Co. bought a new position in shares of Synopsys during the 4th quarter valued at about $36,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Stock Performance

Shares of SNPS stock opened at $378.46 on Tuesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $651.73. The company has a market capitalization of $72.47 billion, a P/E ratio of 87.61, a PEG ratio of 2.26 and a beta of 1.22. The stock has a 50 day moving average price of $466.55 and a two-hundred day moving average price of $457.80.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 EPS for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The company had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the previous year, the firm earned $3.67 earnings per share. The firm’s revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Insider Transactions at Synopsys

In related news, CFO Shelagh Glaser sold 3,394 shares of the firm’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the transaction, the chief executive officer owned 75,020 shares in the company, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the company. KeyCorp restated an “overweight” rating on shares of Synopsys in a research report on Thursday, May 28th. Robert W. Baird set a $558.00 price target on shares of Synopsys in a research note on Thursday, May 28th. Bank of America boosted their price objective on shares of Synopsys from $515.00 to $600.00 and gave the stock a “buy” rating in a report on Thursday, May 28th. Benchmark began coverage on shares of Synopsys in a research note on Wednesday, July 15th. They issued a “buy” rating and a $570.00 price objective for the company. Finally, BNP Paribas Exane increased their target price on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a report on Thursday, May 28th. Two investment analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $570.06.

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Mizuho said Moonshot’s Kimi K3 model supports the long-term agentic AI thesis for electronic design automation software, and reiterated that investors may want to buy the dip in Synopsys and Cadence Design Systems. Buy the dip in EDA stocks as Kimi K3 boosts agentic AI thesis: Mizuho
• Positive Sentiment: Market commentary noted Synopsys shares were edging higher in premarket trading as improving sentiment and an oversold RSI encouraged bargain hunting. What’s Going on With Synopsys stock on Monday?
• Neutral Sentiment: Traders are watching whether SNPS can hold an important technical price level, which could lead to a larger move if the stock reverses from here. Stock Of The Day: Will Synopsys Reverse?
• Negative Sentiment: Synopsys remains under pressure from the broader semiconductor downturn, as the SOX index has fallen into a bear market and investors worry the AI-driven rally may be fading. Semiconductor stocks enter bear market: Is bubble burst next?
• Negative Sentiment: Although Synopsys benefits from AI chip demand regardless of which company wins the AI race, investors appear focused on the stock’s poor post-earnings performance and weak momentum. Synopsys Should Benefit No Matter Who Wins The AI Race. Here’s What Explains Its Poor Stock Performance.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.